Report Detail
Global Oxcarbazepine Market Insights, Forecast to 2025
- RnM3686890 |
- 21 August, 2019 |
- Global |
- 148 Pages |
- QYResearch |
- Pharma & Healthcare
Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group. The presence of an extra oxygen atom in the structure reduces the susceptibility of the drug to hepatic metabolism, leading to prolonged pharmacological action or half life of the drug.
The global Oxcarbazepine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oxcarbazepine market based on company, product type, end user and key regions.
This report studies the global market size of Oxcarbazepine in key regions like North America, Europe, China and India, focuses on the consumption of Oxcarbazepine in these regions.
This research report categorizes the global Oxcarbazepine market by top players/brands, region, type and end user. This report also studies the global Oxcarbazepine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Ranbaxy Pharmaceuticals
Jubilant Generics
Taro Pharmaceuticals
Mylan
Stada Group
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceutical
Roxane Laboratories
Nobelpharma
Apotex
Nexgen pharma
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Neuraxpharm
Orion Corporation
Sihuan Pharm
Humanwell Healthcare
Huikang Pharmaceutical
Oxcarbazepine market size by Type
Tablets (150mg, 300mg, 600mg)
Oral Suspension
Oxcarbazepine market size by Applications
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oxcarbazepine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oxcarbazepine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oxcarbazepine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oxcarbazepine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oxcarbazepine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Unit). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oxcarbazepine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Oxcarbazepine Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Oxcarbazepine Market Size Growth Rate by Type
- 1.4.2 Tablets (150mg, 300mg, 600mg)
- 1.4.3 Oral Suspension
- 1.5 Market by Application
- 1.5.1 Global Oxcarbazepine Market Size Growth Rate by Application
- 1.5.2 Pediatric Use (Aged 2-4 years, 4-16 years)
- 1.5.3 Adult Use
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oxcarbazepine Market Size
- 2.1.1 Global Oxcarbazepine Revenue 2014-2025
- 2.1.2 Global Oxcarbazepine Sales 2014-2025
- 2.2 Oxcarbazepine Growth Rate by Regions
- 2.2.1 Global Oxcarbazepine Sales by Regions
- 2.2.2 Global Oxcarbazepine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Oxcarbazepine Sales by Manufacturers
- 3.1.1 Oxcarbazepine Sales by Manufacturers
- 3.1.2 Oxcarbazepine Sales Market Share by Manufacturers
- 3.2 Oxcarbazepine Revenue by Manufacturers
- 3.2.1 Oxcarbazepine Revenue by Manufacturers (2014-2019)
- 3.2.2 Oxcarbazepine Revenue Share by Manufacturers (2014-2019)
- 3.3 Oxcarbazepine Price by Manufacturers
- 3.4 Oxcarbazepine Manufacturing Base Distribution, Product Types
- 3.4.1 Oxcarbazepine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oxcarbazepine Product Type
- 3.4.3 Date of International Manufacturers Enter into Oxcarbazepine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Oxcarbazepine Sales by Type
- 4.2 Global Oxcarbazepine Revenue by Type
- 4.3 Oxcarbazepine Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Oxcarbazepine Breakdown Data by Application
6 North America
- 6.1 North America Oxcarbazepine by Country
- 6.1.1 North America Oxcarbazepine Sales by Country
- 6.1.2 North America Oxcarbazepine Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Oxcarbazepine by Type
- 6.3 North America Oxcarbazepine by Application
7 Europe
- 7.1 Europe Oxcarbazepine by Country
- 7.1.1 Europe Oxcarbazepine Sales by Country
- 7.1.2 Europe Oxcarbazepine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oxcarbazepine by Type
- 7.3 Europe Oxcarbazepine by Application
8 Asia Pacific
- 8.1 Asia Pacific Oxcarbazepine by Region
- 8.1.1 Asia Pacific Oxcarbazepine Sales by Region
- 8.1.2 Asia Pacific Oxcarbazepine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
- 8.2 Asia Pacific Oxcarbazepine by Type
- 8.3 Asia Pacific Oxcarbazepine by Application
9 Central & South America
- 9.1 Central & South America Oxcarbazepine by Country
- 9.1.1 Central & South America Oxcarbazepine Sales by Country
- 9.1.2 Central & South America Oxcarbazepine Revenue by Country
- 9.1.3 Brazil
- 9.2 Central & South America Oxcarbazepine by Type
- 9.3 Central & South America Oxcarbazepine by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Oxcarbazepine by Country
- 10.1.1 Middle East and Africa Oxcarbazepine Sales by Country
- 10.1.2 Middle East and Africa Oxcarbazepine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Oxcarbazepine by Type
- 10.3 Middle East and Africa Oxcarbazepine by Application
11 Company Profiles
- 11.1 Novartis (Trileptal)
- 11.1.1 Novartis (Trileptal) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis (Trileptal) Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis (Trileptal) Oxcarbazepine Products Offered
- 11.1.5 Novartis (Trileptal) Recent Development
- 11.2 Supernus Pharmaceuticals (Oxtellar XR)
- 11.2.1 Supernus Pharmaceuticals (Oxtellar XR) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Products Offered
- 11.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Development
- 11.3 Sun Pharm
- 11.3.1 Sun Pharm Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sun Pharm Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sun Pharm Oxcarbazepine Products Offered
- 11.3.5 Sun Pharm Recent Development
- 11.4 Ranbaxy Pharmaceuticals
- 11.4.1 Ranbaxy Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Ranbaxy Pharmaceuticals Oxcarbazepine Products Offered
- 11.4.5 Ranbaxy Pharmaceuticals Recent Development
- 11.5 Jubilant Generics
- 11.5.1 Jubilant Generics Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Jubilant Generics Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Jubilant Generics Oxcarbazepine Products Offered
- 11.5.5 Jubilant Generics Recent Development
- 11.6 Taro Pharmaceuticals
- 11.6.1 Taro Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Taro Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Taro Pharmaceuticals Oxcarbazepine Products Offered
- 11.6.5 Taro Pharmaceuticals Recent Development
- 11.7 Mylan
- 11.7.1 Mylan Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Mylan Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Mylan Oxcarbazepine Products Offered
- 11.7.5 Mylan Recent Development
- 11.8 Stada Group
- 11.8.1 Stada Group Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Stada Group Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Stada Group Oxcarbazepine Products Offered
- 11.8.5 Stada Group Recent Development
- 11.9 Glenmark Pharmaceuticals
- 11.9.1 Glenmark Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Glenmark Pharmaceuticals Oxcarbazepine Products Offered
- 11.9.5 Glenmark Pharmaceuticals Recent Development
- 11.10 ANI Pharmaceuticals
- 11.10.1 ANI Pharmaceuticals Company Details
- 11.10.2 Company Business Overview
- 11.10.3 ANI Pharmaceuticals Oxcarbazepine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 ANI Pharmaceuticals Oxcarbazepine Products Offered
- 11.10.5 ANI Pharmaceuticals Recent Development
- 11.11 Teva Pharmaceutical
- 11.12 Roxane Laboratories
- 11.13 Nobelpharma
- 11.14 Apotex
- 11.15 Nexgen pharma
- 11.16 Amneal Pharmaceuticals
- 11.17 Hikma Pharmaceuticals
- 11.18 Jamp Pharma
- 11.19 Neuraxpharm
- 11.20 Orion Corporation
- 11.21 Sihuan Pharm
- 11.22 Humanwell Healthcare
- 11.23 Huikang Pharmaceutical
12 Future Forecast
- 12.1 Oxcarbazepine Market Forecast by Regions
- 12.1.1 Global Oxcarbazepine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oxcarbazepine Revenue Forecast by Regions 2019-2025
- 12.2 Oxcarbazepine Market Forecast by Type
- 12.2.1 Global Oxcarbazepine Sales Forecast by Type 2019-2025
- 12.2.2 Global Oxcarbazepine Revenue Forecast by Type 2019-2025
- 12.3 Oxcarbazepine Market Forecast by Application
- 12.4 North America Oxcarbazepine Forecast
- 12.5 Europe Oxcarbazepine Forecast
- 12.6 Asia Pacific Oxcarbazepine Forecast
- 12.7 Central & South America Oxcarbazepine Forecast
- 12.8 Middle East and Africa Oxcarbazepine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oxcarbazepine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oxcarbazepine. Industry analysis & Market Report on Oxcarbazepine is a syndicated market report, published as Global Oxcarbazepine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oxcarbazepine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
